# Erlotinib Before and After Surgery in Treating Patients With Muscle-Invasive Bladder Cancer

> **NCT00380029** · PHASE2 · COMPLETED · sponsor: **UNC Lineberger Comprehensive Cancer Center** · enrollment: 27 (actual)

## Conditions studied

- Bladder Cancer

## Interventions

- **DRUG:** Erlotinib
- **PROCEDURE:** Radical Cystectomy

## Key facts

- **NCT ID:** NCT00380029
- **Lead sponsor:** UNC Lineberger Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2010-08
- **Final completion:** 2014-06
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2017-07-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00380029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00380029, "Erlotinib Before and After Surgery in Treating Patients With Muscle-Invasive Bladder Cancer". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00380029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*